TRCT
GRI

Tower Research Capital (TRC)’s GRI Bio GRI Stock Holding History

Tower Research Capital (TRC)’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31K Buy
2,434
+1,374
+130% +$3.04K ﹤0.01% 4405
2026
Q1 		$2.43K Buy
1,060
+958
+939% +$3.57K ﹤0.01% 4482
2025
Q4 		$704 Sell
102
-42
-29% -$1.81K ﹤0.01% 4840
2025
Q3 		$8.29K Buy
144
+7
+5% +$324 ﹤0.01% 4052
2025
Q2 		$4.95K Buy
137
+92
+204% +$3.83K ﹤0.01% 4245
2025
Q1 		$4.07K Buy
45
+38
+543% +$9.57K ﹤0.01% 4304
2024
Q4 		$2.89K Sell
7
-2
-22% -$685 ﹤0.01% 4755
2024
Q3 		$1.61K Buy
9
+8
+800% +$3.22K ﹤0.01% 5134
2024
Q2 		$591 Hold
1
– – ﹤0.01% 5297
2024
Q1 		$4.58K Buy
+1
New +$8.53K ﹤0.01% 4660
2023
Q4 		– Hold
0
– – – 5210
2023
Q3 		– Hold
0
– – – 3986
2023
Q2 		– Hold
0
– – – 4042
2023
Q1 		– Hold
0
– – – 5067
2022
Q4 		– Hold
0
– – – 5185
2022
Q3 		– Hold
0
– – – 5391
2022
Q2 		– Hold
0
– – – 4675
2022
Q1 		– Hold
0
– – – 3182
2021
Q4 		– Hold
0
– – – 5026
2021
Q3 		– Hold
0
– – – 5911
2021
Q2 		– Hold
0
– – – 5611

Other funds holding GRI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Tower Research Capital (TRC)'s GRI Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its GRI Bio (GRI) stake by 130% in Q2 2026, buying an estimated $3.04K and bringing the position to 2,434 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #4405.

Tower Research Capital (TRC) first reported a position in GRI in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.29K in Q3 2025. 8 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • Tower Research Capital (TRC) held 2,434 shares of GRI Bio worth $4.31K as of Q2 2026.
  • Tower Research Capital (TRC) bought 1,374 GRI Bio shares in Q2 2026, an estimated $3.04K.
  • GRI Bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4405 holding.
  • Tower Research Capital (TRC) first reported a position in GRI Bio in Q1 2024 and has held it in 10 quarters since.
  • Tower Research Capital (TRC)'s GRI Bio position peaked at $8.29K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.